about us

Inborn BioMedical is strongly committed to improve the efficacy of bone infection treatment by designing innovative biomaterial platform technologies.

"We are a collaborative and supportive team, dedicated to ensure our technology will meets requirements of patients and surgeons in the best possible manner."

Our Mission

To lead the design of effective treatments of infections to enhance patient recovery and optimize healthcare outcomes.

Our Values

To deliver innovative, patient-centered treatments that ensure intracellular killing of bacteria and enhanced tissue healing.

INBORN BIOMEDICAL (1)

“Trained as a material scientist, I am passionate about creating solutions that blend biocompatibility with efficacy. At Inborn, we strive to develop innovative biomaterial platforms that not only treat infections effectively but also promote natural tissue healing.”

Dr. Rong Wang

Co-founder&CEO, Inborn BioMedical

“As a biologist, I am driven by the goal of translating complex scientific insights into real-world solutions. At Inborn, we focus on designing therapies that provide patients with safer, targeted treatments for challenging bone infections.”

Dr. Alexey Klymov

Co-founder&COO, Inborn BioMedical

Meet the team​

We are currently in the process to build up our collaborative and supportive team! Follow us to check opportunities in working with our international team.

Rong Wang, PhD

Co-founder & CEO

Alexey Klymov, PhD

Co-founder & COO

Are you the One

Business Developer

Meet the scientific advisory board

We are currently in the process to build up our supervisory board! Feel free to contact us if you see the click in bringing our solutions to the clinical unmet needs. 

Sander Leeuwenburgh, PhD

Scientific Advisor

Fang Yang, PhD

Technical Advisor

Wim Rijnen, PhD, MD

Clinical Advisor

AB

Business Developer